159 related articles for article (PubMed ID: 15731997)
1. The liver biopsy in chronic hepatitis C: a view from the other side of the microscope.
Kleiner DE
Semin Liver Dis; 2005 Feb; 25(1):52-64. PubMed ID: 15731997
[TBL] [Abstract][Full Text] [Related]
2. The role of liver biopsy in chronic hepatitis C.
Dienstag JL
Hepatology; 2002 Nov; 36(5 Suppl 1):S152-60. PubMed ID: 12407589
[TBL] [Abstract][Full Text] [Related]
3. Histological and nonhistological criteria in the evaluation of liver involvement in chronic hepatitis C.
Mateescu RB; Rimbaş M; Stăniceanu F; Zurac S; Dragomir P; Voiosu MR; Tătaru M; Zota M; Bucurică S
Rom J Intern Med; 2006; 44(2):117-30. PubMed ID: 17236293
[TBL] [Abstract][Full Text] [Related]
4. [Role of liver biopsy in the diagnosis and management of chronic hepatitis C].
Palacios Pérez A; Salmerón Escobar J
Gastroenterol Hepatol; 2007; 30(7):402-7. PubMed ID: 17692199
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive assessment of chronic liver and gastric diseases.
Plebani M; Basso D
Clin Chim Acta; 2007 May; 381(1):39-49. PubMed ID: 17374528
[TBL] [Abstract][Full Text] [Related]
6. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.
Sebastiani G; Vario A; Ferrari A; Pistis R; Noventa F; Alberti A
J Viral Hepat; 2006 Mar; 13(3):199-205. PubMed ID: 16475996
[TBL] [Abstract][Full Text] [Related]
7. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.
Cross TJ; Quaglia A; Hughes S; Joshi D; Harrison PM
J Viral Hepat; 2009 Jul; 16(7):492-9. PubMed ID: 19200134
[TBL] [Abstract][Full Text] [Related]
8. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
[TBL] [Abstract][Full Text] [Related]
9. Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults.
Sulkowski MS; Mehta SH; Torbenson MS; Higgins Y; Brinkley SC; de Oca RM; Moore RD; Afdhal NH; Thomas DL
AIDS; 2007 Oct; 21(16):2209-16. PubMed ID: 18090048
[TBL] [Abstract][Full Text] [Related]
10. [Role of liver biopsy in chronic hepatitis C].
Aguirre García J
Rev Gastroenterol Mex; 2002 Oct; 67 Suppl 2():S27-8. PubMed ID: 12712849
[TBL] [Abstract][Full Text] [Related]
11. Increased T-cell sinusoidal lymphocytosis in liver biopsies in patients with chronic hepatitis C and mixed cryoglobulinemia.
Carmack S; Taddei T; Robert ME; Mistry P; Jain D
Am J Gastroenterol; 2008 Mar; 103(3):705-11. PubMed ID: 17970837
[TBL] [Abstract][Full Text] [Related]
12. Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.
Masarone M; La Mura V; Bruno S; Gaeta GB; Vecchione R; Carrino F; Moschella F; Torella R; Persico M
J Viral Hepat; 2007 Oct; 14(10):714-20. PubMed ID: 17875006
[TBL] [Abstract][Full Text] [Related]
13. A follow-up study to determine the value of liver biopsy and need for antiviral therapy for hepatitis C virus carriers with persistently normal serum aminotransferase.
Okanoue T; Makiyama A; Nakayama M; Sumida Y; Mitsuyoshi H; Nakajima T; Yasui K; Minami M; Itoh Y
J Hepatol; 2005 Oct; 43(4):599-605. PubMed ID: 16024129
[TBL] [Abstract][Full Text] [Related]
14. Management of chronic hepatitis C.
Asselah T; Boyer N; Ripault MP; Martinot M; Marcellin P
Minerva Gastroenterol Dietol; 2007 Mar; 53(1):9-23. PubMed ID: 17415342
[TBL] [Abstract][Full Text] [Related]
15. Disease progression in Chinese chronic hepatitis C patients with persistently normal alanine aminotransaminase levels.
Hui CK; Zhang HY; Shek T; Yao H; Yueng YH; Leung KW; Lai ST; Lai JY; Leung N; Lau GK
Aliment Pharmacol Ther; 2007 Jun; 25(11):1283-92. PubMed ID: 17509096
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 years.
Persico M; Perrotta S; Persico E; Terracciano L; Folgori A; Ruggeri L; Nicosia A; Vecchione R; Mura VL; Masarone M; Torella R
J Viral Hepat; 2006 May; 13(5):290-6. PubMed ID: 16637858
[TBL] [Abstract][Full Text] [Related]
17. Assessment of fibrosis progression in untreated irish women with chronic hepatitis C contracted from immunoglobulin anti-D.
Levine RA; Sanderson SO; Ploutz-Snyder R; Murray F; Kay E; Hegarty J; Nolan N; Kelleher D; McDonald G; O'Keane JC; Crowe J
Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1271-7. PubMed ID: 16901770
[TBL] [Abstract][Full Text] [Related]
18. [Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection].
Stránský J; Ryzlová M; Striteský J; Horák J
Vnitr Lek; 2002 Oct; 48(10):924-8. PubMed ID: 16737138
[TBL] [Abstract][Full Text] [Related]
19. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
Sanai FM; Benmousa A; Al-Hussaini H; Ashraf S; Alhafi O; Abdo AA; Alameri HF; Akbar HO; Bzeizi KI
Liver Int; 2008 Aug; 28(7):1011-8. PubMed ID: 18384520
[TBL] [Abstract][Full Text] [Related]
20. Progression of liver fibrosis among injection drug users with chronic hepatitis C.
Wilson LE; Torbenson M; Astemborski J; Faruki H; Spoler C; Rai R; Mehta S; Kirk GD; Nelson K; Afdhal N; Thomas DL
Hepatology; 2006 Apr; 43(4):788-95. PubMed ID: 16557548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
